Lantz Financial LLC Gsk PLC Transaction History

Lantz Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	SELL	$38.11 - $42.99 $198,286 - $223,676	-5,203 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$37.87 - $43.58 $95,129 - $109,472	-2,512 Reduced 32.56%	5,203 $212,000
Q1 2020 Apr 10, 2020	SELL	$32.47 - $48.83 $16,267 - $24,463	-501 Reduced 6.1%	7,715 $292,000
Q4 2019 Jan 17, 2020	SELL	$42.0 - $48.25 $25,074 - $28,805	-597 Reduced 6.77%	8,216 $386,000
Q3 2019 Oct 18, 2019	SELL	$40.46 - $43.52 $728 - $783	-18 Reduced 0.2%	8,813 $363,000
Q2 2019 Jul 15, 2019	SELL	$39.4 - $42.7 $243,334 - $263,715	-6,176 Reduced 41.15%	8,831 $361,000
Q1 2019 Apr 22, 2019	BUY	$38.57 - $42.69 $578,819 - $640,648	15,007 New	15,007 $627,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Lantz Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lantz Financial LLC with notifications on news.